... B6.129 F1 B6.129 F1 + + + Wnt3avt/vt + + Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Egfrwa2/wa2 Total activitya Daytime ... the analysis and discussion of the results, and in the writing of the manuscript CLT participated in all experiments, in the analysis and discussion of the results, and in the writing of the manuscript ... experiments and in the analysis and discussion of the results DWT participated in the conceptualization of the experiments, in the analysis and discussion of the results, and in the writing of the...
... treatment of head and neck cancers are low grade and cutaneous The rationale for combination of inhibitors ofEGFR with ionizing radiation is, therefore, a potentially attractive combination for recurrent ... Expression ofepidermalgrowthfactor receptors in human brain tumors Cancer Res 1984, 44:753-760 Westermark B, Magnusson A, Heldin CH: Effects ofepidermalgrowthfactor on membrane motility and cell ... Sanfilippo JS, Rao CV, Guarnascelli JJ: Detection ofepidermalgrowthfactorand transforming growthfactor alpha protein in meningiomas and other tumors of central nervous system in human beings Surg...
... carcinoma of the head and neck 10 RT: radiation therapy EGF: epidermalgrowthfactor EGFR: epidermalgrowthfactorreceptor 11 TGF-α: transforming growthfactor alpha 12 RTOG: Radiation Therapy Oncology ... association with epidermalgrowthfactor receptor/ transforming growthfactor alpha expression in head and neck squamous carcinoma and inhibition by anti -epidermal growthfactorreceptor treatments ... Elevated levels of transforming growthfactor α andepidermalgrowthfactorreceptor messenger RNA are early markers of carcinogenesis in head and neck cancer Cancer Res 1993, 53:3579-3584 Grandis JR,...
... Korsmeyer SJ & Streuli CH (2002) Activation of BAD by therapeutic inhibition ofepidermalgrowthfactorreceptorand transactivation by insulin-like growthfactorreceptor J Biol Chem 277, 27643–27650 ... 2316–2326 11 Anderson NG, Ahmad T, Chan K, Dobson R & Bundred NJ (2001) ZD1839 (Iressa), a novel epidermalgrowthfactorreceptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growthof EGFRpositive ... fetal calf serum and used for all of the experiments PC-9 cells were plated 24 h before transfection and co-transfected with 8.5 lg of pcDL-SRa 296JNK2(VPF) or pcMKP-1 and 1.5 lg of pBabePuro by...
... domain ofepidermalgrowthfactorreceptor Cell 125, 1137–1149 Voldborg BR, Damstrup L, Spang-Thomsen M & Poulsen HS (1997) Epidermalgrowthfactorreceptor (EGFR) andEGFR mutations, function and ... T & Yatabe Y (2007) Mutations of the epidermalgrowthfactorreceptor gene and related genes as determinants ofepidermalgrowthfactorreceptor tyrosine kinase inhibitors sensitivity in lung ... (2006) Kinetic analysis ofepidermalgrowthfactorreceptor somatic mutant proteins shows increased sensitivity to the epidermalgrowthfactorreceptor tyrosine kinase inhibitor, erlotinib Cancer Res...
... treatment of CML provided compelling evidence for the effectiveness of small-molecule tyrosine kinase inhibitors (TKIs) and triggered the developmentof this class of agents for targeting growthfactor ... expressing both T790M mutant and wild-type forms of EGFR, EGFR- TKIs are not able to inhibit the phosphorylation of either type of the receptor The T790M mutation ofEGFR was initially thought to ... growthfactor receptors frequently expressed in epithelial cancers [9] Two such inhibitors of the tyrosine kinase activity ofEGFR (EGFR- TKIs), gefitinib and erlotinib, compete with ATP for binding...
... 5578 17 Ono M & Kuwano M (2006) Molecular mechanisms ofepidermalgrowthfactorreceptor (EGFR) activation and response to gefitinib and other EGFR- targeting drugs Clin Cancer Res 12, 7242–7251 ... the growthof PC9 cells and tube formation of ECV304 cells (A) PC9 cells (5 · 103) cells were plated on 96-well plates Forty-eight hours later, MTT was added to each well for h at 37 °C, and ... regulate EGFR pathways are critical to our understanding of lung cancer developmentand progression Emerging evidence has revealed the profound role of various miRNAs in regulating cancer development...
... time of transfection Lipofectamine 2000 was diluted in serum-free DMEM and mixed with dsRNA at a 1:2 ratio (4 µl of 20 µmol/L of siRNA formulated with µl of Lipofectamine 2000) The formulation of ... Figure The effects of dsRNA -EGFR on A549 (A) and SPC-A1 (B) cell count and colony formation (C) The effects of dsRNA -EGFR on A549 (A) and SPC-A1 (B) cell count and colony formation (C) Cells ... active inhibitorofepidermalgrowthfactor signaling with potential for cancer therapy Cancer Res 2002, 62:5749-5764 Shin DM, Donato NJ, Perez-Soler R, et al.: Epidermalgrowthfactor receptor- targeted...
... activation of the epidermalgrowthfactorand nerve growthfactor receptors J Biol Chem 271, 30505–30509 Browaeys-Poly E, Cailliau K & Vilain JP (1998) Fibroblast andepidermalgrowthfactorreceptor ... ATP, andepidermalgrowthfactor in epithelial LLC-PK1 cells Am J Physiol 265, C966–C975 29 Elliget KA, Phelps PC & Smith MW (1996) Transforming growthfactor b modulation of the epidermalgrowth ... (2005) A structural model for the membrane-bound form of the juxtamembrane domain of the epidermalgrowthfactorreceptor J Biol Chem 280, 24043–24052 Calmodulin and the EGFR 58 Sato T, Pallavi...
... starved for h before lysis and immunoprecipitation of Hrs as described above Hrs was eluted in sample buffer for SDS/PAGE peGFP -EGFR was expressed in SYF-2 cells andand starved for h before stimulating ... surface of early endosomes J Biol Chem 272, 20538–20544 27 Ebner, R & Derynck, R (1991) Epidermalgrowthfactorand transforming growth factor- alpha: differential intracellular routing and processing ... serum-starved and stimulated with EGF or TGFa before the cells were washed and Hrs was immunoprecipitated from the lysate We chose to stimulate the cells with the growth factors for min, as the growth factor- stimulated...
... marker for indicating the intrinsic kinase activity of EGFR, regardless of tissue type Results Ligand-induced transcriptional signatures of EGFR- WT and L858R in the absence or presence ofEGFR ... activation ofEGFR is systemically and evolutionarily guaranteed by the presence of a variety of ligands, or by dimerization and trans-activation with other family member receptors of ErbB [2,3] ... EGFR mutation and MIG6 expression T Nagashima et al Introduction Epidermalgrowthfactorreceptor (EGFR) is a membrane tyrosine kinase that is involved in the regulation of a wide variety of...
... Biochemical and clinical implications of the ErbB/HER signaling network ofgrowthfactor receptors Adv Cancer Res 2000, 77:25-79 Diasio RB, Furie J: Targeting the epidermalgrowthfactorreceptor ... the epidermalgrowthfactorreceptor by immunohistochemestry J Clin Oncol 2005, 23(9):1803-1811 Moroni M, veronese S, Benvenuti S, et al.: Gene copy number forepidermalgrowthfactorreceptorand ... evidence of the predictive role of EGFR- GCN in terms of RR, PFS and OS in a retrospective series of 101 patients affected by advanced CRC and treated with chemotherapy plus Cetuximab The role of kras...
... promoter region and exons 18-21 of the EGFR genes (Table 1) PCR amplification of 0.2 μg DNA was performed with a denaturing step at 94°C for min, then 30 sec at 94°C, at 58°C, and at 72°C for 35 cycles, ... Multiplex PCR and primer extension analysis of mutations in EGFR- 216 promoter region and exons 18, 19, 20, and 21 Multiplex PCR was used to amplify the promoter region and exons 18-21 of the EGFR genes ... terms of the amount of work and time required With this method, -216 promoter region and exons 18-21 of the EGFR gene were amplified with multiplex PCR in a single tube and the detection of mutations...
... Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermalgrowthfactorreceptor 2-positive metastatic Syrios et al Journal of ... human epidermalgrowthfactorreceptor 2; MBC: metastatic breast cancer Authors’ contributions JS collected and analyzed the data of the study and wrote the manuscript AD collected the data of the ... different end points and eligibility criteria; however, the understanding of trastuzumabrelated cardiac events has since improved, and the majority of these events are manageable and reversible Extending...
... factorreceptor cascade The mechanism ofEGFR expression and activation Stimulation of airway epithelial cells with TNF-α causes EGFR expression (the extracellular and intracellular parts ofEGFR ... express EGFR constitutively, and contain few goblet cells [4] Instillation of tumor necrosis factor (TNF)-α induced EGFR expression in the airway epithelium, and subsequent instillation ofEGFR ligand ... M , Nasuhara Y, Sato A, Takahashi T, Homma Y, Kawakami Y: Expression ofepidermalgrowthfactorandepidermalgrowthfactorreceptor immunoreactivity in the asthmatic human airway Am J Respir...
... roles forEGFR signaling in the regulation of circadian rhythms by the SCN EGFRandEGFR ligands are expressed throughout the central nervous system and are involved in diverse developmental and ... expression ofEGFR [9-11] and transforming growthfactor alpha (TGF-alpha; an EGFR ligand) [9,10,12,13] have been reported EGFR signaling has been implicated in the circadian regulation of locomotor ... significance threshold of 2% for PAINT, CONS and ChIP enrichments, and a significance threshold of 5% for circadian gene enrichments pM(LOCAL) values are for standard normalization results and gene group...
... gives an introduction of the epidermalgrowthfactorreceptor (EGFR) The introduction starts from a history ofEGFR study, and focuses on the function and clinical importance of EGFR, its structure, ... influence of lipid rafts, cytoskeleton, andreceptor activation on the mobility ofEGFR Chapter concludes and presents an outlook for future FCS and FCCS developments for a better understanding of biological ... regulation forreceptor autophosphorylation and/ or transformation ofreceptor activity (Chang, Shu et al 1995; Frederick, Wang et al 2000; Bose and Zhang 2009) 1.1.3 The cycle ofEGFR in a cell Before...
... a ni setunim 01 rof selpmas eht gniliob yb deraperp saw nietorp latot ehT )ASU ,daR-oiB( tik sisylana drofdarB a gnisu denimreted saw noitartnecnoc nietorp ehT C ta nim 03 rof × 000,41 ta degufirtnec ... eussit racs evissecxe fo noitamrof eht gnisaerced ni elor a syalp ti saerehw ,ssecorp riaper dnuow eht secnahne FGE deilppa yllacipot ,elpmaxe roF ]91[ noitamrof racs no ecneulfni yna gnivah ... ,enelyx ni deziniffaraped ,h rof C 34 ta detabucni erew snoitces ehT sedils detaoc nisyl-ylop no detnuom dna tuc erew snoitces kciht mm eviF niffarap ni deddebme dna ,nilamrof lartuen %01 ni dexif...
... 1.09 (CI 0.76–1.54) for class I, 1.5 (CI 0.92–2.46) for class II, and 2.78 (CI 1.56–4.94) for class III (Table 2) The p values were 64 for class I, 10 for class II, and 0005 for class III When ... unit of increased BMI Table Demographics of Total Evaluated and Included Patients Characteristics Number of subjects evaluated Number of subjects included Number of subjects excluded Reasons of ... 005) in all subjects For men, this risk was 3.4% (CI 1.01–1.06) for one unit of increased BMI (1 kg/m2) andfor women 2% (CI 0.97–1.07), respectively The OR for point estimates of AHR risk in obesity...
... (1993) A 40-kDa epidermalgrowth factor/ transforming growthfactor a-binding domain produced by limited proteolysis of the extracellular domain of the epidermalgrowthfactorreceptor J Biol ... of hydrophobicity of the tyrosine at position 13 of human growthfactor in receptor binding J Biol Chem 268, 10114–10119 26 Campion, S.R & Niyogi, S.K (1994) Interaction ofepidermalgrowthfactor ... Richards, K.M et al (2001) Identification of a determinant ofepidermalgrowthfactorreceptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain Biochemistry 40, 8930–8939...